Researchers develop a new means of killing harmful bacteria
Engineered particles are capable of producing toxins that are deadly to targeted bacteria.
Engineered particles are capable of producing toxins that are deadly to targeted bacteria.
Optimal size and shape allow implantable devices to last longer in the body.
MIT-Spain co-director describes how a La Caixa Fellowship impacted her research at MIT and led to the creation of the MIT-Spain Program.
Bhatia is recognized for her work in tissue engineering, disease detection, and advocacy for women in STEM.
Award to Professor Alex Shalek will support new advances in nanotechnology and chemical biology.
Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs.
Emery Brown says anesthesia drugs have been used in the U.S. for more than 160 years, but were largely misunderstood — until now.
Daniel Anderson wants to bring advances in drug delivery and biomaterials to the clinic.
Molecule stays in the bloodstream and is turned on when blood sugar levels are too high.
Study yields insight into generating antibodies that target different strains of HIV.
Liver cells derived from stem cells can be infected with malaria and used to test potential drugs.
Award honors one engineer’s global impact on human health.
Twelve new faces join six academic departments in the School of Engineering.